Looking forward to the rest of the symposium, including the presentation of Verena Jendrossek, who will talk about her research in the radiation therapy field ☢️
We are looking forward to the #NorwegianCancerSymposium2024 celebrating the 70th anniversary of the Institute for Cancer Research, Oslo University Hospital. The prominent Douglas Hanahan, keynote speaker, kicks off the conference!
Seminar for the Dept. of Radiation Biology, ICR, @Oslounivsykehus on radiation and immune responses. First, excellent talk by invited speaker @vilded. Then, perspectives from group leaders, and group discussions. Great event for networking and exchange of ideas and experience☢️
One gantry in the new proton therapy facilities @Oslounivsykehus Radiumhospitalet is scheduled to be operational in December☢️ Right now, the cyclotron is being cooled down to 4 Kelvin🥶 This morning, Sigbjørn Smeland gave an update on the constructions at Radiumhospitalet.
🆕 Join our first #Immunotherapy course! Explore immune-tumour interactions and learn how to amplify anti-tumour responses. Course Co-Director @GaiplS provides an exclusive glimpse into the course content. Watch the video!
ℹ️ https://t.co/UR7MtBzkvT
#radonc#radiotherapy
From fractionation studies to understanding the mechanism behind the #FLASH effect, there's a lot to explore.
🚀For a quick catch-up on FLASH #radiotherapy, read the full article in the #Biology Corner of the #ESTRONewsletter: https://t.co/8UOuNloZK3 #radonc
From the 16th International Wolfsberg Meeting on Molecular Radiation Biology/Oncology now in the green journal.
https://t.co/TJBNJSdjA5
@RadiotherapyOn1 @ESTRO_RT#radonc#radiobiology
And from Bucharest, Romania: Diana Savu, IFIN-HH:
"Research in proton and carbon ion radiobiology at IFIN-HH".
Time: 13:00
Place: K04 120 (Research building K)
Anyone who is interested is welcome!
Guest lectures hosted by Randi Syljuåsen, TODAY at the Institute for Cancer Research, Oslo University Hospital:
From Caen, France: Francois Chevalier (CEA, DRF- IRAMIS-CIMAP): "Radiation-biology of radioresistant cancer models and bystander effects in a context of hadrontherapy"
We seek a new Unit Leader for our Preclinical Proton Therapy and Imaging Unit at the Institute for Cancer Research, Oslo University Hospital. In connection with establishing a new proton therapy center at our Hospital. Deadline 1st December
https://t.co/zbhiXdb0Sg
Do you have a background in preclinical research within biophysics, radiotherapy and radiobiology? The new preclinical proton therapy core facility at the Institute for Cancer Research, Oslo University Hospital, is hiring a unit leader: https://t.co/cCQsg0uXVK Closing Dec 1
Congratulations to Lilli Bay from the Department of Radiation Biology, Oslo University Hospital, on her successful defense of the PhD thesis “Interplay between the transcription machinery and the responses to DNA damage and replication stress” 🧬🔧 Very impressive!
Time: 10-11.
Place: J-building, room J3055.
Marianne Farnebo, will give the talk "An RNA story - from DNA to protein" and Barbara van Loon, NTNU, will present "Non-canonical functions of AAG DNA glycosylase in gene expression and associated impacts on behaviour".
Upcoming seminar October 25th at the Institute for Cancer Research, Oslo University Hospital: Marianne Farnebo, Karolinska Institutet, and Barbara van Loon, NTNU, will present their work related to DNA repair. 🧬🔧
Congratulations to Adrian Eek Mariampillai from the Department of Radiation Biology, Oslo University Hospital, on the successful defense of his doctoral thesis "Assessment of immunogenic signalling from cancer cells after irradiation and ATR inhibition". Well done 🥳
⏳ The countdown has started! Share your groundbreaking research in radiation oncology with experts from around the world, submit your abstract for ESTRO 2024 by 25 October:
👉 https://t.co/WVC6KFvM0I
#ESTRO24#Radonc
RadOncs treating lung cancer – last chance to share your opinions on cardiotoxicity!
Survey is anonymous, takes ~7mins & closes Mon 9th Oct
https://t.co/YQnTYBQdRg
Thank you to everyone who has participated so far!
@gerryhanna@joshmitchellmd @QubPGJCCR @ICOSociety
📢 Call for Candidates: Editor-in-Chief of Radiotherapy & Oncology, flagship journal of ESTRO and the #radonc community. Are you the ideal successor to uphold its high standards of excellence and commitment to advancing the field of RO?
📅 Apply by 25 Oct: https://t.co/RQ6UNlPwEr